Global Urology Market
Global Urology Market

Urology Comprehensive Study by Therapies (Medications, Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)}, Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others}), End Users (Hospitals & Clinics, Ambulatory Surgical Centers, Dialysis Centers, Nephrological Centers), Disease Type (Benign prostatic hyperplasia, Cancer, Urinary Tract Infection, Stone Diseases, Others), Gender (Male, Female) Players and Region - Global Market Outlook to 2027

Urology Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Jun 2022 Edition 234 Pages 71 Tables & Figures
Sample Report Speak with Analyst Request Discount
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Urology Market Scope
Urology, also known as genitourinary surgery is a branch of medicine that focuses on the medical conditions of urinary systems diseases. Increasing urinary conditions including kidney stone and prostate problems in people due to changes in lifestyle and inadequate physical exercise have created noteworthy growth for the market. Further, more and more urologists are shifting towards the adoption of cutting-edge medical devices to treat patients with low invasion and perform surgical processes rapidly. In the surgical process, robotic surgeries are gaining much popularity and are extensively applied for the treatment of prostate cancer as it allows access to anatomical areas that are difficult to reach in non-robotic surgeries.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledAdvanced MedTech (Singapore), Ribbel International Ltd. (India), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (United States), Stryker Corporation (United States), Well Lead Medical Co., Ltd. (China), Medtronic (Ireland), Boston Scientific Corporation (United States), Cook Medical (United States), Teleflex Incorporated (United States), Cardinal Health (United States), Amsino International, Inc. (United States), Olympus Corporation (Japan) and Baxter International (United States)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Urology market throughout the predicted period.

Advanced MedTech (Singapore), Ribbel International Ltd. (India), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (United States), Stryker Corporation (United States), Well Lead Medical Co., Ltd. (China), Medtronic (Ireland), Boston Scientific Corporation (United States), Cook Medical (United States), Teleflex Incorporated (United States), Cardinal Health (United States), Amsino International, Inc. (United States), Olympus Corporation (Japan) and Baxter International (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Urology market and Region with country level break-up.

On the basis of geography, the market of Urology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

In May 2022, Teleflex Incorporated announced the launch of the UroLift 2 System and UroLift ATC Advanced Tissue Control System in the United States. The company is a leading provider of medical technologies. The company's UroLift 2 System will help urologists to improve workflow while UroLift ATC System will allow treating patients with a broad range of anatomies including obstructive middle lobes.


Market Trend
  • Emerging Trend of Miniaturization and Development of Optical Technology and Robotics Constitute for Surgical Procedures
  • Significant Inclination Towards Telemedicine During and Post Pandemic for Treating Some Common Urological Conditions

Opportunities
  • Increasing Number of People With Urinary Tract Infection in Asian Countries Especially in Developing Economies

Restraints
  • High Cost Associated with Advanced and Innovative Urology Devices and Treatments, Lack of Awareness May Slow Down the Growth of the Market in Underdeveloped Countries and Rural Areas

Challenges
  • Chances of Mechanical Failure and Accidental Burn Injuries in Robotic Surgeries As Well As Requirement of Longer Duration to Perform Robot-Assisted Surgery


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Urology Treatment Providers, Urology Drugs & Devices Manufacturers, Urology Drugs & Devices Suppliers and Distributors, Venture Capitalists and Private Equity Firms, Regulatory Bodies, Research Organizations, End-Users and Others

Frequently Asked Questions (FAQ):

1. What are the key segments playing vital role in Urology Market?
The Urology study can be customized to meet your requirements. The market size breakdown by type [], by end use application [].

2. How big is the Urology Market?
The Urology Market is gaining popularity and expected to see strong valuation by 2027.

3. What are the key driving factors for the growth of the Urology Market?
  • Increasing Urological Problems Including Urinary Incontinence and Prostate Cancer in Men Due to Smoking Habits and High Body Mass Index
  • Growing Popularity of Minimally Invasive Treatments to Reduce the Invasiveness of Interventions
  • Continuous Growth of Urology Procedures in the Ambulatory Surgical Centers and Outpatient Sites


Report Objectives / Segmentation Covered
By Therapies
  • Medications
  • Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)}
  • Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others}

By End Users
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Dialysis Centers
  • Nephrological Centers

By Disease Type
  • Benign prostatic hyperplasia
  • Cancer
  • Urinary Tract Infection
  • Stone Diseases
  • Others

By Gender
  • Male
  • Female

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Urological Problems Including Urinary Incontinence and Prostate Cancer in Men Due to Smoking Habits and High Body Mass Index
      • 3.2.2. Growing Popularity of Minimally Invasive Treatments to Reduce the Invasiveness of Interventions
      • 3.2.3. Continuous Growth of Urology Procedures in the Ambulatory Surgical Centers and Outpatient Sites
    • 3.3. Market Challenges
      • 3.3.1. Chances of Mechanical Failure and Accidental Burn Injuries in Robotic Surgeries As Well As Requirement of Longer Duration to Perform Robot-Assisted Surgery
    • 3.4. Market Trends
      • 3.4.1. Emerging Trend of Miniaturization and Development of Optical Technology and Robotics Constitute for Surgical Procedures
      • 3.4.2. Significant Inclination Towards Telemedicine During and Post Pandemic for Treating Some Common Urological Conditions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Urology, by Therapies, End Users, Disease Type, Gender and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Urology (Value)
      • 5.2.1. Global Urology by: Therapies (Value)
        • 5.2.1.1. Medications
        • 5.2.1.2. Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)}
        • 5.2.1.3. Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others}
      • 5.2.2. Global Urology by: End Users (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Ambulatory Surgical Centers
        • 5.2.2.3. Dialysis Centers
        • 5.2.2.4. Nephrological Centers
      • 5.2.3. Global Urology by: Disease Type (Value)
        • 5.2.3.1. Benign prostatic hyperplasia
        • 5.2.3.2. Cancer
        • 5.2.3.3. Urinary Tract Infection
        • 5.2.3.4. Stone Diseases
        • 5.2.3.5. Others
      • 5.2.4. Global Urology by: Gender (Value)
        • 5.2.4.1. Male
        • 5.2.4.2. Female
      • 5.2.5. Global Urology Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Urology (Price)
  • 6. Urology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Advanced MedTech (Singapore)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ribbel International Ltd. (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Stryker Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Well Lead Medical Co., Ltd. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medtronic (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Boston Scientific Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cook Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teleflex Incorporated (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Cardinal Health (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Amsino International, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Olympus Corporation (Japan)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Baxter International (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Urology Sale, by Therapies, End Users, Disease Type, Gender and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Urology (Value)
      • 7.2.1. Global Urology by: Therapies (Value)
        • 7.2.1.1. Medications
        • 7.2.1.2. Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)}
        • 7.2.1.3. Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others}
      • 7.2.2. Global Urology by: End Users (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Ambulatory Surgical Centers
        • 7.2.2.3. Dialysis Centers
        • 7.2.2.4. Nephrological Centers
      • 7.2.3. Global Urology by: Disease Type (Value)
        • 7.2.3.1. Benign prostatic hyperplasia
        • 7.2.3.2. Cancer
        • 7.2.3.3. Urinary Tract Infection
        • 7.2.3.4. Stone Diseases
        • 7.2.3.5. Others
      • 7.2.4. Global Urology by: Gender (Value)
        • 7.2.4.1. Male
        • 7.2.4.2. Female
      • 7.2.5. Global Urology Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Urology (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Urology: by Therapies(USD Million)
  • Table 2. Urology Medications , by Region USD Million (2016-2021)
  • Table 3. Urology Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)} , by Region USD Million (2016-2021)
  • Table 4. Urology Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others} , by Region USD Million (2016-2021)
  • Table 5. Urology: by End Users(USD Million)
  • Table 6. Urology Hospitals & Clinics , by Region USD Million (2016-2021)
  • Table 7. Urology Ambulatory Surgical Centers , by Region USD Million (2016-2021)
  • Table 8. Urology Dialysis Centers , by Region USD Million (2016-2021)
  • Table 9. Urology Nephrological Centers , by Region USD Million (2016-2021)
  • Table 10. Urology: by Disease Type(USD Million)
  • Table 11. Urology Benign prostatic hyperplasia , by Region USD Million (2016-2021)
  • Table 12. Urology Cancer , by Region USD Million (2016-2021)
  • Table 13. Urology Urinary Tract Infection , by Region USD Million (2016-2021)
  • Table 14. Urology Stone Diseases , by Region USD Million (2016-2021)
  • Table 15. Urology Others , by Region USD Million (2016-2021)
  • Table 16. Urology: by Gender(USD Million)
  • Table 17. Urology Male , by Region USD Million (2016-2021)
  • Table 18. Urology Female , by Region USD Million (2016-2021)
  • Table 19. South America Urology, by Country USD Million (2016-2021)
  • Table 20. South America Urology, by Therapies USD Million (2016-2021)
  • Table 21. South America Urology, by End Users USD Million (2016-2021)
  • Table 22. South America Urology, by Disease Type USD Million (2016-2021)
  • Table 23. South America Urology, by Gender USD Million (2016-2021)
  • Table 24. Brazil Urology, by Therapies USD Million (2016-2021)
  • Table 25. Brazil Urology, by End Users USD Million (2016-2021)
  • Table 26. Brazil Urology, by Disease Type USD Million (2016-2021)
  • Table 27. Brazil Urology, by Gender USD Million (2016-2021)
  • Table 28. Argentina Urology, by Therapies USD Million (2016-2021)
  • Table 29. Argentina Urology, by End Users USD Million (2016-2021)
  • Table 30. Argentina Urology, by Disease Type USD Million (2016-2021)
  • Table 31. Argentina Urology, by Gender USD Million (2016-2021)
  • Table 32. Rest of South America Urology, by Therapies USD Million (2016-2021)
  • Table 33. Rest of South America Urology, by End Users USD Million (2016-2021)
  • Table 34. Rest of South America Urology, by Disease Type USD Million (2016-2021)
  • Table 35. Rest of South America Urology, by Gender USD Million (2016-2021)
  • Table 36. Asia Pacific Urology, by Country USD Million (2016-2021)
  • Table 37. Asia Pacific Urology, by Therapies USD Million (2016-2021)
  • Table 38. Asia Pacific Urology, by End Users USD Million (2016-2021)
  • Table 39. Asia Pacific Urology, by Disease Type USD Million (2016-2021)
  • Table 40. Asia Pacific Urology, by Gender USD Million (2016-2021)
  • Table 41. China Urology, by Therapies USD Million (2016-2021)
  • Table 42. China Urology, by End Users USD Million (2016-2021)
  • Table 43. China Urology, by Disease Type USD Million (2016-2021)
  • Table 44. China Urology, by Gender USD Million (2016-2021)
  • Table 45. Japan Urology, by Therapies USD Million (2016-2021)
  • Table 46. Japan Urology, by End Users USD Million (2016-2021)
  • Table 47. Japan Urology, by Disease Type USD Million (2016-2021)
  • Table 48. Japan Urology, by Gender USD Million (2016-2021)
  • Table 49. India Urology, by Therapies USD Million (2016-2021)
  • Table 50. India Urology, by End Users USD Million (2016-2021)
  • Table 51. India Urology, by Disease Type USD Million (2016-2021)
  • Table 52. India Urology, by Gender USD Million (2016-2021)
  • Table 53. South Korea Urology, by Therapies USD Million (2016-2021)
  • Table 54. South Korea Urology, by End Users USD Million (2016-2021)
  • Table 55. South Korea Urology, by Disease Type USD Million (2016-2021)
  • Table 56. South Korea Urology, by Gender USD Million (2016-2021)
  • Table 57. Australia Urology, by Therapies USD Million (2016-2021)
  • Table 58. Australia Urology, by End Users USD Million (2016-2021)
  • Table 59. Australia Urology, by Disease Type USD Million (2016-2021)
  • Table 60. Australia Urology, by Gender USD Million (2016-2021)
  • Table 61. Rest of Asia-Pacific Urology, by Therapies USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Urology, by End Users USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Urology, by Disease Type USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Urology, by Gender USD Million (2016-2021)
  • Table 65. Europe Urology, by Country USD Million (2016-2021)
  • Table 66. Europe Urology, by Therapies USD Million (2016-2021)
  • Table 67. Europe Urology, by End Users USD Million (2016-2021)
  • Table 68. Europe Urology, by Disease Type USD Million (2016-2021)
  • Table 69. Europe Urology, by Gender USD Million (2016-2021)
  • Table 70. Germany Urology, by Therapies USD Million (2016-2021)
  • Table 71. Germany Urology, by End Users USD Million (2016-2021)
  • Table 72. Germany Urology, by Disease Type USD Million (2016-2021)
  • Table 73. Germany Urology, by Gender USD Million (2016-2021)
  • Table 74. France Urology, by Therapies USD Million (2016-2021)
  • Table 75. France Urology, by End Users USD Million (2016-2021)
  • Table 76. France Urology, by Disease Type USD Million (2016-2021)
  • Table 77. France Urology, by Gender USD Million (2016-2021)
  • Table 78. Italy Urology, by Therapies USD Million (2016-2021)
  • Table 79. Italy Urology, by End Users USD Million (2016-2021)
  • Table 80. Italy Urology, by Disease Type USD Million (2016-2021)
  • Table 81. Italy Urology, by Gender USD Million (2016-2021)
  • Table 82. United Kingdom Urology, by Therapies USD Million (2016-2021)
  • Table 83. United Kingdom Urology, by End Users USD Million (2016-2021)
  • Table 84. United Kingdom Urology, by Disease Type USD Million (2016-2021)
  • Table 85. United Kingdom Urology, by Gender USD Million (2016-2021)
  • Table 86. Netherlands Urology, by Therapies USD Million (2016-2021)
  • Table 87. Netherlands Urology, by End Users USD Million (2016-2021)
  • Table 88. Netherlands Urology, by Disease Type USD Million (2016-2021)
  • Table 89. Netherlands Urology, by Gender USD Million (2016-2021)
  • Table 90. Rest of Europe Urology, by Therapies USD Million (2016-2021)
  • Table 91. Rest of Europe Urology, by End Users USD Million (2016-2021)
  • Table 92. Rest of Europe Urology, by Disease Type USD Million (2016-2021)
  • Table 93. Rest of Europe Urology, by Gender USD Million (2016-2021)
  • Table 94. MEA Urology, by Country USD Million (2016-2021)
  • Table 95. MEA Urology, by Therapies USD Million (2016-2021)
  • Table 96. MEA Urology, by End Users USD Million (2016-2021)
  • Table 97. MEA Urology, by Disease Type USD Million (2016-2021)
  • Table 98. MEA Urology, by Gender USD Million (2016-2021)
  • Table 99. Middle East Urology, by Therapies USD Million (2016-2021)
  • Table 100. Middle East Urology, by End Users USD Million (2016-2021)
  • Table 101. Middle East Urology, by Disease Type USD Million (2016-2021)
  • Table 102. Middle East Urology, by Gender USD Million (2016-2021)
  • Table 103. Africa Urology, by Therapies USD Million (2016-2021)
  • Table 104. Africa Urology, by End Users USD Million (2016-2021)
  • Table 105. Africa Urology, by Disease Type USD Million (2016-2021)
  • Table 106. Africa Urology, by Gender USD Million (2016-2021)
  • Table 107. North America Urology, by Country USD Million (2016-2021)
  • Table 108. North America Urology, by Therapies USD Million (2016-2021)
  • Table 109. North America Urology, by End Users USD Million (2016-2021)
  • Table 110. North America Urology, by Disease Type USD Million (2016-2021)
  • Table 111. North America Urology, by Gender USD Million (2016-2021)
  • Table 112. United States Urology, by Therapies USD Million (2016-2021)
  • Table 113. United States Urology, by End Users USD Million (2016-2021)
  • Table 114. United States Urology, by Disease Type USD Million (2016-2021)
  • Table 115. United States Urology, by Gender USD Million (2016-2021)
  • Table 116. Canada Urology, by Therapies USD Million (2016-2021)
  • Table 117. Canada Urology, by End Users USD Million (2016-2021)
  • Table 118. Canada Urology, by Disease Type USD Million (2016-2021)
  • Table 119. Canada Urology, by Gender USD Million (2016-2021)
  • Table 120. Mexico Urology, by Therapies USD Million (2016-2021)
  • Table 121. Mexico Urology, by End Users USD Million (2016-2021)
  • Table 122. Mexico Urology, by Disease Type USD Million (2016-2021)
  • Table 123. Mexico Urology, by Gender USD Million (2016-2021)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Urology: by Therapies(USD Million)
  • Table 139. Urology Medications , by Region USD Million (2022-2027)
  • Table 140. Urology Surgery {Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Transurethral Electrovaporization, Holmium Laser Enucleation of Prostate (HoLEP)} , by Region USD Million (2022-2027)
  • Table 141. Urology Minimally Invasive Treatments {Prostatic Urethral lift, Water Vapor therapy, Laser Treatment, Others} , by Region USD Million (2022-2027)
  • Table 142. Urology: by End Users(USD Million)
  • Table 143. Urology Hospitals & Clinics , by Region USD Million (2022-2027)
  • Table 144. Urology Ambulatory Surgical Centers , by Region USD Million (2022-2027)
  • Table 145. Urology Dialysis Centers , by Region USD Million (2022-2027)
  • Table 146. Urology Nephrological Centers , by Region USD Million (2022-2027)
  • Table 147. Urology: by Disease Type(USD Million)
  • Table 148. Urology Benign prostatic hyperplasia , by Region USD Million (2022-2027)
  • Table 149. Urology Cancer , by Region USD Million (2022-2027)
  • Table 150. Urology Urinary Tract Infection , by Region USD Million (2022-2027)
  • Table 151. Urology Stone Diseases , by Region USD Million (2022-2027)
  • Table 152. Urology Others , by Region USD Million (2022-2027)
  • Table 153. Urology: by Gender(USD Million)
  • Table 154. Urology Male , by Region USD Million (2022-2027)
  • Table 155. Urology Female , by Region USD Million (2022-2027)
  • Table 156. South America Urology, by Country USD Million (2022-2027)
  • Table 157. South America Urology, by Therapies USD Million (2022-2027)
  • Table 158. South America Urology, by End Users USD Million (2022-2027)
  • Table 159. South America Urology, by Disease Type USD Million (2022-2027)
  • Table 160. South America Urology, by Gender USD Million (2022-2027)
  • Table 161. Brazil Urology, by Therapies USD Million (2022-2027)
  • Table 162. Brazil Urology, by End Users USD Million (2022-2027)
  • Table 163. Brazil Urology, by Disease Type USD Million (2022-2027)
  • Table 164. Brazil Urology, by Gender USD Million (2022-2027)
  • Table 165. Argentina Urology, by Therapies USD Million (2022-2027)
  • Table 166. Argentina Urology, by End Users USD Million (2022-2027)
  • Table 167. Argentina Urology, by Disease Type USD Million (2022-2027)
  • Table 168. Argentina Urology, by Gender USD Million (2022-2027)
  • Table 169. Rest of South America Urology, by Therapies USD Million (2022-2027)
  • Table 170. Rest of South America Urology, by End Users USD Million (2022-2027)
  • Table 171. Rest of South America Urology, by Disease Type USD Million (2022-2027)
  • Table 172. Rest of South America Urology, by Gender USD Million (2022-2027)
  • Table 173. Asia Pacific Urology, by Country USD Million (2022-2027)
  • Table 174. Asia Pacific Urology, by Therapies USD Million (2022-2027)
  • Table 175. Asia Pacific Urology, by End Users USD Million (2022-2027)
  • Table 176. Asia Pacific Urology, by Disease Type USD Million (2022-2027)
  • Table 177. Asia Pacific Urology, by Gender USD Million (2022-2027)
  • Table 178. China Urology, by Therapies USD Million (2022-2027)
  • Table 179. China Urology, by End Users USD Million (2022-2027)
  • Table 180. China Urology, by Disease Type USD Million (2022-2027)
  • Table 181. China Urology, by Gender USD Million (2022-2027)
  • Table 182. Japan Urology, by Therapies USD Million (2022-2027)
  • Table 183. Japan Urology, by End Users USD Million (2022-2027)
  • Table 184. Japan Urology, by Disease Type USD Million (2022-2027)
  • Table 185. Japan Urology, by Gender USD Million (2022-2027)
  • Table 186. India Urology, by Therapies USD Million (2022-2027)
  • Table 187. India Urology, by End Users USD Million (2022-2027)
  • Table 188. India Urology, by Disease Type USD Million (2022-2027)
  • Table 189. India Urology, by Gender USD Million (2022-2027)
  • Table 190. South Korea Urology, by Therapies USD Million (2022-2027)
  • Table 191. South Korea Urology, by End Users USD Million (2022-2027)
  • Table 192. South Korea Urology, by Disease Type USD Million (2022-2027)
  • Table 193. South Korea Urology, by Gender USD Million (2022-2027)
  • Table 194. Australia Urology, by Therapies USD Million (2022-2027)
  • Table 195. Australia Urology, by End Users USD Million (2022-2027)
  • Table 196. Australia Urology, by Disease Type USD Million (2022-2027)
  • Table 197. Australia Urology, by Gender USD Million (2022-2027)
  • Table 198. Rest of Asia-Pacific Urology, by Therapies USD Million (2022-2027)
  • Table 199. Rest of Asia-Pacific Urology, by End Users USD Million (2022-2027)
  • Table 200. Rest of Asia-Pacific Urology, by Disease Type USD Million (2022-2027)
  • Table 201. Rest of Asia-Pacific Urology, by Gender USD Million (2022-2027)
  • Table 202. Europe Urology, by Country USD Million (2022-2027)
  • Table 203. Europe Urology, by Therapies USD Million (2022-2027)
  • Table 204. Europe Urology, by End Users USD Million (2022-2027)
  • Table 205. Europe Urology, by Disease Type USD Million (2022-2027)
  • Table 206. Europe Urology, by Gender USD Million (2022-2027)
  • Table 207. Germany Urology, by Therapies USD Million (2022-2027)
  • Table 208. Germany Urology, by End Users USD Million (2022-2027)
  • Table 209. Germany Urology, by Disease Type USD Million (2022-2027)
  • Table 210. Germany Urology, by Gender USD Million (2022-2027)
  • Table 211. France Urology, by Therapies USD Million (2022-2027)
  • Table 212. France Urology, by End Users USD Million (2022-2027)
  • Table 213. France Urology, by Disease Type USD Million (2022-2027)
  • Table 214. France Urology, by Gender USD Million (2022-2027)
  • Table 215. Italy Urology, by Therapies USD Million (2022-2027)
  • Table 216. Italy Urology, by End Users USD Million (2022-2027)
  • Table 217. Italy Urology, by Disease Type USD Million (2022-2027)
  • Table 218. Italy Urology, by Gender USD Million (2022-2027)
  • Table 219. United Kingdom Urology, by Therapies USD Million (2022-2027)
  • Table 220. United Kingdom Urology, by End Users USD Million (2022-2027)
  • Table 221. United Kingdom Urology, by Disease Type USD Million (2022-2027)
  • Table 222. United Kingdom Urology, by Gender USD Million (2022-2027)
  • Table 223. Netherlands Urology, by Therapies USD Million (2022-2027)
  • Table 224. Netherlands Urology, by End Users USD Million (2022-2027)
  • Table 225. Netherlands Urology, by Disease Type USD Million (2022-2027)
  • Table 226. Netherlands Urology, by Gender USD Million (2022-2027)
  • Table 227. Rest of Europe Urology, by Therapies USD Million (2022-2027)
  • Table 228. Rest of Europe Urology, by End Users USD Million (2022-2027)
  • Table 229. Rest of Europe Urology, by Disease Type USD Million (2022-2027)
  • Table 230. Rest of Europe Urology, by Gender USD Million (2022-2027)
  • Table 231. MEA Urology, by Country USD Million (2022-2027)
  • Table 232. MEA Urology, by Therapies USD Million (2022-2027)
  • Table 233. MEA Urology, by End Users USD Million (2022-2027)
  • Table 234. MEA Urology, by Disease Type USD Million (2022-2027)
  • Table 235. MEA Urology, by Gender USD Million (2022-2027)
  • Table 236. Middle East Urology, by Therapies USD Million (2022-2027)
  • Table 237. Middle East Urology, by End Users USD Million (2022-2027)
  • Table 238. Middle East Urology, by Disease Type USD Million (2022-2027)
  • Table 239. Middle East Urology, by Gender USD Million (2022-2027)
  • Table 240. Africa Urology, by Therapies USD Million (2022-2027)
  • Table 241. Africa Urology, by End Users USD Million (2022-2027)
  • Table 242. Africa Urology, by Disease Type USD Million (2022-2027)
  • Table 243. Africa Urology, by Gender USD Million (2022-2027)
  • Table 244. North America Urology, by Country USD Million (2022-2027)
  • Table 245. North America Urology, by Therapies USD Million (2022-2027)
  • Table 246. North America Urology, by End Users USD Million (2022-2027)
  • Table 247. North America Urology, by Disease Type USD Million (2022-2027)
  • Table 248. North America Urology, by Gender USD Million (2022-2027)
  • Table 249. United States Urology, by Therapies USD Million (2022-2027)
  • Table 250. United States Urology, by End Users USD Million (2022-2027)
  • Table 251. United States Urology, by Disease Type USD Million (2022-2027)
  • Table 252. United States Urology, by Gender USD Million (2022-2027)
  • Table 253. Canada Urology, by Therapies USD Million (2022-2027)
  • Table 254. Canada Urology, by End Users USD Million (2022-2027)
  • Table 255. Canada Urology, by Disease Type USD Million (2022-2027)
  • Table 256. Canada Urology, by Gender USD Million (2022-2027)
  • Table 257. Mexico Urology, by Therapies USD Million (2022-2027)
  • Table 258. Mexico Urology, by End Users USD Million (2022-2027)
  • Table 259. Mexico Urology, by Disease Type USD Million (2022-2027)
  • Table 260. Mexico Urology, by Gender USD Million (2022-2027)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Urology: by Therapies USD Million (2016-2021)
  • Figure 5. Global Urology: by End Users USD Million (2016-2021)
  • Figure 6. Global Urology: by Disease Type USD Million (2016-2021)
  • Figure 7. Global Urology: by Gender USD Million (2016-2021)
  • Figure 8. South America Urology Share (%), by Country
  • Figure 9. Asia Pacific Urology Share (%), by Country
  • Figure 10. Europe Urology Share (%), by Country
  • Figure 11. MEA Urology Share (%), by Country
  • Figure 12. North America Urology Share (%), by Country
  • Figure 13. Global Urology share by Players 2021 (%)
  • Figure 14. Global Urology share by Players (Top 3) 2021(%)
  • Figure 15. Global Urology share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Advanced MedTech (Singapore) Revenue, Net Income and Gross profit
  • Figure 18. Advanced MedTech (Singapore) Revenue: by Geography 2021
  • Figure 19. Ribbel International Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 20. Ribbel International Ltd. (India) Revenue: by Geography 2021
  • Figure 21. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 22. B. Braun Melsungen AG (Germany) Revenue: by Geography 2021
  • Figure 23. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton, Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 25. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Stryker Corporation (United States) Revenue: by Geography 2021
  • Figure 27. Well Lead Medical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 28. Well Lead Medical Co., Ltd. (China) Revenue: by Geography 2021
  • Figure 29. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic (Ireland) Revenue: by Geography 2021
  • Figure 31. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 33. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cook Medical (United States) Revenue: by Geography 2021
  • Figure 35. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 36. Teleflex Incorporated (United States) Revenue: by Geography 2021
  • Figure 37. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 38. Cardinal Health (United States) Revenue: by Geography 2021
  • Figure 39. Amsino International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Amsino International, Inc. (United States) Revenue: by Geography 2021
  • Figure 41. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 42. Olympus Corporation (Japan) Revenue: by Geography 2021
  • Figure 43. Baxter International (United States) Revenue, Net Income and Gross profit
  • Figure 44. Baxter International (United States) Revenue: by Geography 2021
  • Figure 45. Global Urology: by Therapies USD Million (2022-2027)
  • Figure 46. Global Urology: by End Users USD Million (2022-2027)
  • Figure 47. Global Urology: by Disease Type USD Million (2022-2027)
  • Figure 48. Global Urology: by Gender USD Million (2022-2027)
  • Figure 49. South America Urology Share (%), by Country
  • Figure 50. Asia Pacific Urology Share (%), by Country
  • Figure 51. Europe Urology Share (%), by Country
  • Figure 52. MEA Urology Share (%), by Country
  • Figure 53. North America Urology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Advanced MedTech (Singapore)
  • Ribbel International Ltd. (India)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (United States)
  • Stryker Corporation (United States)
  • Well Lead Medical Co., Ltd. (China)
  • Medtronic (Ireland)
  • Boston Scientific Corporation (United States)
  • Cook Medical (United States)
  • Teleflex Incorporated (United States)
  • Cardinal Health (United States)
  • Amsino International, Inc. (United States)
  • Olympus Corporation (Japan)
  • Baxter International (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount
Slider
Slider
Slider
DOWNLOAD SAMPLE PDF

Speak with Analyst

Want to find out more about this report?

Get Free Consultation
Ask a Question!

Related Reports

Antibody Discovery Comprehensive Study by Type (Monoclonal Antibodies, Polyclonal Antibodies, Other Antibodies), Nature (Humanized, Human, Chimeric, Murine), Methods (Phage Display, Hybridoma, Transg...
Antibody Discovery Comprehensive Study by Type (Monoclonal Antibodies, Polyclonal Antibodies, Other Antibodies), Nature (Humanized, Human, Chimeric, Murine), Methods (Phage Display, Hybridoma, Transg...
$ 3800